Paracetamol: Difference between revisions

Content deleted Content added
m Reverted 2 edits by 103.100.4.173 (talk) to last revision by DSatz
The word "only" is subjective and inappropriate for an encyclopedic lead section. "Only" compared to what? Sentences should state facts, not judgements.
 
(10 intermediate revisions by 9 users not shown)
Line 3:
{{cs1 config|name-list-style=vanc|display-authors=6}}
{{drugbox
| Watchedfields = changed
| verifiedrevid = 456349142
| image = N-Acetyl-p-aminophenol.svg
| width = 210
| alt =
| caption =
| width2 =
| alt2 =
| imageL = Paracetamol-from-xtal-3D-balls.png
| imageR = Paracetamol-from-xtal-3D-vdW.png
| USAN = acetaminophen
 
<!-- Clinical data -->| pronounce = Paracetamol: {{IPAc-en|ˌ|p|ær|ə|ˈ|s|iː|t|ə|m|ɒ|l}}<br />Acetaminophen: {{IPAc-en|audio=En-acetaminophen.oga|ə|ˌ|s|iː|t|ə|ˈ|m|ɪ|n|ə|f|ɪ|n}}
| tradename = [[Tylenol (brand)|Tylenol]], [[Panadol (brand)|Panadol]], [[Paracetamol brand names|others]]<ref name=drugs.com-internatl>{{drugs.com|international| acetaminophen}}</ref>
| Drugs.com = {{drugs.com|monograph|acetaminophen}}
| MedlinePlus = a681004
| DailyMedID = Acetaminophen
| pregnancy_AU = A
| pregnancy_AU_comment = <ref name="Drugs.com pregnancy">{{cite web |title=Acetaminophen Use During Pregnancy |website=Drugs.com |date=14 June 2019 |url=https://www.drugs.com/pregnancy/acetaminophen.html |access-date=25 February 2020 |archive-date=9 March 2020 |archive-url=https://web.archive.org/web/20200309154313/https://www.drugs.com/pregnancy/acetaminophen.html |url-status=live }}</ref>
| pregnancy_category =
| routes_of_administration = [[Oral administration|OralBy mouth]] (by mouth), [[rectal administration|rectal]], [[intravenous administration|intravenous]] (IV)
| class = {{plainlist|
| class = [[Analgesic]]s and [[antipyretic]]s
*[[Analgesic]];
| ATC_prefix = N02
*[[antipyretic]]}}
| ATC_suffix = BE01
| ATC_prefix = N02
| ATC_supplemental = {{ATC|N02|BE51}} {{ATC|N02|BE71}}
| ATC_suffix = BE01
| ATC_supplemental = {{ATC|N02|BE51}} {{ATC|N02|BE71}}
 
<!-- Legal status -->| legal_AU = S4
| legal_AU_comment = OTC, and unscheduled
| legal_BR = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F-->
| legal_BR_comment =
| legal_CA = OTC
| legal_CA_comment = /&nbsp;Rx-only<ref>{{cite web |url=https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?lang=en&linkID=RDS00565 |title=Regulatory Decision Summary – Acetaminophen Injection |website=[[Health Canada]] |date=23 October 2014 |access-date=7 June 2022 |archive-date=7 June 2022 |archive-url=https://web.archive.org/web/20220607080419/https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?lang=en&linkID=RDS00565 |url-status=live }}</ref>
| legal_DE = <!-- Anlage I, II, III or Unscheduled-->
| legal_DE_comment =
| legal_NZ = <!-- Class A, B, C -->
| legal_NZ_comment =
| legal_UK = GSL
| legal_UK_comment =
| legal_US = OTC
| legal_US_comment = /&nbsp;Rx-only
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_UN_comment =
| legal_status = [[China|CN]]: = <![[Over-the-Forcounter countries not listed above-->drug|OTC]]
 
<!-- Pharmacokinetic data -->| bioavailability = 63–89%<ref>{{cite book |isbn=978-0-9873236-7-5 |title=Acute Pain Management: Scientific Evidence |veditors=Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J |vauthors=((Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine)) |year=2015 |edition=4th |publisher=Australian and New Zealand College of Anaesthetists (ANZCA), Faculty of Pain Medicine (FPM) |location=Melbourne |url=http://fpm.anzca.edu.au/documents/apmse4_2015_final |format=PDF |access-date=28 October 2019 |archive-url=https://web.archive.org/web/20190731120330/http://fpm.anzca.edu.au/documents/apmse4_2015_final |archive-date=31 July 2019 |url-status=dead }}</ref>{{rp|73}}
| protein_bound = negligible to 10–25% in overdose<ref name="pmid7039926"/>
| metabolism = Predominantly in the [[liver]]<ref name = TGA>{{cite web|title=Codapane Forte Paracetamol and codeine phosphate product information|work=TGA eBusiness Services|publisher=Alphapharm Pty Limited|date=29 April 2013|access-date=10 May 2014|url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05623-3|format=PDF|archive-date=6 February 2016|archive-url=https://web.archive.org/web/20160206163239/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05623-3|url-status=live}}</ref>
| metabolites = APAP [[Glucuronide|gluc]], APAP [[sulfate]], APAP [[Glutathione|GSH]], APAP [[cys]], AM404, [[NAPQI]]<ref>{{cite web |title= Acetaminophen Pathway (therapeutic doses), Pharmacokinetics |url= https://www.pharmgkb.org/pathway/PA165986279 |access-date= 13 January 2016 |url-status= dead |archive-url= https://web.archive.org/web/20160304220600/https://www.pharmgkb.org/pathway/PA165986279 |archive-date= 4 March 2016 }}</ref>
| onset = Pain relief onset by [[Route ofOral administration|routeOral]]:<br />[[Oral administration|oral]]{{nbsp}}– 37{{nbsp}}minutes<ref name="Buccal route">{{cite journal |vauthors = Pickering G, Macian N, Libert F, Cardot JM, Coissard S, Perovitch P, Maury M, Dubray C |title = Buccal acetaminophen provides fast analgesia: two randomized clinical trials in healthy volunteers |journal = Drug Design, Development and Therapy| volume = 8 |pages = 1621–1627 |date = September 2014 |pmid = 25302017 |pmc = 4189711 |doi = 10.2147/DDDT.S63476 |quote = In postoperative conditions for acute pain of mild to moderate intensity, the quickest reported time to onset of analgesia with APAP is 8 minutes9 for the iv route and 37 minutes6 for the oral route. |doi-access = free }}</ref><br />[[Intravenous]]{{nbsp}}–: 8{{nbsp}}minutes<ref name="Buccal route" />
| elimination_half-life = 1.9–2.5 hours<ref name="pmid7039926"/>
| duration_of_action =
| excretion = [[Kidney]]<ref name="pmid7039926"/>
 
<!-- Identifiers -->| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 103-90-2
| CAS_supplemental =
| PubChem = 1983
| PubChemSubstance = 46506142
| IUPHAR_ligand = 5239
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00316
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 1906
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 362O9ITL9D
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00217
| KEGG2 = C06804
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 46195
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 112
| NIAID_ChemDB =
| PDB_ligand = TYL
| synonyms = ''N''-acetyl-''para''-aminophenol (APAP)
 
<!-- Chemical and physical data -->| IUPAC_name = ''N''-(4-hydroxyphenyl)ethanamide
| C = 8
| H = 9
| N = 1
| O = 2
| SMILES = CC(=O)Nc1ccc(O)cc1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)
| StdInChI_comment =
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RZVAJINKPMORJF-UHFFFAOYSA-N
| density = 1.263
| density_notes =
| melting_point = 169
| melting_high =
| melting_notes = <ref>{{cite journal |doi = 10.1021/ci0500132 |title = General Melting Point Prediction Based on a Diverse Compound Data Set and Artificial Neural Networks |year = 2005 |vauthors=Karthikeyan M, Glen RC, Bender A |journal = Journal of Chemical Information and Modeling |volume = 45 |issue = 3 |pages = 581–590 |pmid = 15921448|s2cid = 13017241 }}</ref><ref>{{cite web |url = http://lxsrv7.oru.edu/~alang/meltingpoints/meltingpointof.php?csid=1906 |title = melting point data for paracetamol |publisher = Lxsrv7.oru.edu |access-date = 19 March 2011 |url-status = dead |archive-url = https://archive.today/20120630213835/http://lxsrv7.oru.edu/~alang/meltingpoints/meltingpointof.php?csid=1906 |archive-date = 30 June 2012 }}</ref>
| boiling_point =
| boiling_notes =
| solubility = {{ubl| 7.21{{nbsp}}g/kg (0{{nbsp}}°C)<ref name="paracetamol-solubility">{{cite journal| doi = 10.1021/je990124v| title = Solubility of paracetamol in pure solvents| vauthors=Granberg RA, Rasmuson AC| journal = [[Journal of Chemical & Engineering Data]]| volume = 44 |issue = 6 |pages = 1391–95| year = 1999}}</ref>| 8.21{{nbsp}}g/kg (5{{nbsp}}°C)<ref name="paracetamol-solubility" />| 9.44{{nbsp}}g/kg (10{{nbsp}}°C)<ref name="paracetamol-solubility" />| 10.97{{nbsp}}g/kg (15{{nbsp}}°C)<ref name="paracetamol-solubility" />| 12.78{{nbsp}}g/kg (20{{nbsp}}°C)<ref name="paracetamol-solubility" />| ~14{{nbsp}}mg/ml (20{{nbsp}}°C)}}
| sol_units =
| specific_rotation =
}}
<!-- Definition and medical uses -->
 
'''Paracetamol''' ('''acetaminophen'''{{Efn|Commonly called "acetaminophen" in the US, Canada, Japan, South Korea, and Colombia{{cn|date=April 2024}}}}) is a non-opioid [[analgesic]] and [[antipyretic]] agent used to treat [[fever]] and mild to moderate [[pain]].<ref name=":2">{{cite journal | vauthors = Prescott LF | title = Paracetamol: past, present, and future | journal = American Journal of Therapeutics | volume = 7 | issue = 2 | pages = 143–147 | date = March 2000 | pmid = 11319582 | doi = 10.1097/00045391-200007020-00011 | s2cid = 7754908 }}</ref><ref name="pmid19058473" /><ref name= "pmid31892511" /> It is a widely used [[over the counter|over-the-counter]] [[medication]]. Common brand names include [['''Tylenol (brand)|Tylenol]]''' and [['''Panadol (brand)|Panadol]]'''.
 
At a standard dose, paracetamol only slightly reduces fever;<ref name="pmid19058473"/><ref name="pmid27992852"/><ref name= "pmid26518691"/> it is inferior to [[ibuprofen]] in that respect,<ref name="pmid20150507"/> and the benefits of its use for fever are unclear, particularly in the context of fever of viral origins.<ref name="pmid19058473"/><ref name="pmid12076499">{{cite journal |vauthors=Meremikwu M, Oyo-Ita A |title=Paracetamol for treating fever in children |journal=Cochrane Database Syst Rev |volume= 2002|issue=2 |pages= CD003676 |date=2002 |pmid=12076499 |pmc=6532671 |doi=10.1002/14651858.CD003676}}</ref><ref name="pmid31116598"/> Paracetamol relieves pain in both acute mild [[migraine]] and episodic [[tension headache]].<ref name="pmid25600718"/><ref name="pmid27306653"/> The [[aspirin/paracetamol/caffeine]] combination also helps with both conditions where the pain is mild and is recommended as a [[Therapy#Lines of therapy|first-line treatment]] for them.<ref name="pmid29671521" /><ref name= "pmid21181425"/> Paracetamol is effective for post-[[surgical]] pain, but it is inferior to ibuprofen.<ref name="pmid24338830"/> The paracetamol/ibuprofen combination provides further increase in potency and is superior to either [[drug]] alone.<ref name="pmid24338830"/><ref name="pmid23904576"/> The pain relief paracetamol provides in [[osteoarthritis]] is small and clinically insignificant.<ref name="pmid31892511"/><ref name=BMJ2015/><ref name="pmid31908149"/> The evidence in its favor for the use in low back pain, [[cancer pain]], and [[neuropathic pain]] is insufficient.<ref name="pmid31892511"/><ref name="pmid28192789"/><ref name=BMJ2015/><ref name=Saragiotto2016/><ref name="pmid28700092"/><ref name="pmid28027389"/>
 
<!-- Side effects and mechanism-->
In the short term, paracetamol is safe and effective when used as directed.<ref>{{cite web |date=11 October 2012 |title=Acetaminophen |url=https://www.canada.ca/en/health-canada/services/drugs-medical-devices/acetaminophen.html |access-date=22 September 2022 |website=[[Health Canada]] |url-status=live |archive-date=3 November 2022 |archive-url=https://web.archive.org/web/20221103234259/https://www.canada.ca/en/health-canada/services/drugs-medical-devices/acetaminophen.html}}</ref> Short term adverse effects are uncommon and similar to [[ibuprofen]],<ref>{{cite journal |vauthors=Southey ER, Soares-Weiser K, Kleijnen J |title=Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever |journal=Current Medical Research and Opinion |volume=25 |issue=9 |pages=2207–2222 |date=September 2009 |pmid=19606950 |doi=10.1185/03007990903116255 |s2cid=31653539 |url=https://figshare.com/articles/journal_contribution/11815293 |access-date=2 December 2022 |archive-date=3 January 2023 |archive-url= https://web.archive.org/web/20230103023230/https://figshare.com/articles/journal_contribution/Systematic_review_and_meta-analysis_of_the_clinical_safety_and_tolerability_of_ibuprofen_compared_with_paracetamol_in_paediatric_pain_and_fever/11815293 |url-status=live}}</ref> but paracetamol is typically safer than [[non-steroidalNonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drugs]]s (NSAIDNSAIDs) for long-term use.<ref>{{cite web |title=Acetaminophen vs Ibuprofen: Which is better? |url=https://www.drugs.com/medical-answers/difference-between-ibuprofen-acetaminophen-3016163/ |access-date=22 September 2022 |website=Drugs.com |archive-date=19 February 2023 |archive-url=https://web.archive.org/web/20230219010941/https://www.drugs.com/medical-answers/difference-between-ibuprofen-acetaminophen-3016163/ |url-status=live }}</ref> Paracetamol is also often used in patients who cannot tolerate NSAIDs like [[ibuprofen]].<ref name="pmid31156845">{{cite journal |vauthors=Moore RA, Moore N |title=Paracetamol and pain: the kiloton problem |journal=European Journal of Hospital Pharmacy |volume=23 |issue=4 |pages=187–188 |date=July 2016 |pmid=31156845 |pmc=6451482 |doi=10.1136/ejhpharm-2016-000952 |doi-access=free |title-link=doi}}</ref><ref name="pmid31073920"/> Chronic consumption of paracetamol may result in a drop in [[hemoglobin]] level, indicating possible [[gastrointestinal bleeding]],<ref name="pmid25732175"/> and [[Elevated transaminases|abnormal liver function tests]]. The recommended maximum daily dose for an adult is three to four grams.<ref name="UK2017">{{cite web |url=https://www.nhs.uk/medicines/paracetamol-for-adults/ |title=Paracetamol for adults: painkiller to treat aches, pains and fever |website=[[National Health Service]] |access-date=22 August 2017 |url-status=live |archive-url= https://web.archive.org/web/20170822174155/https://beta.nhs.uk/medicines/paracetamol-for-adults |archive-date=22 August 2017}}</ref><ref name="Med2018">{{cite web |title=What are the recommended maximum daily dosages of acetaminophen in adults and children? |url=https://www.medscape.com/answers/820200-27207/what-are-the-recommended-maximum-daily-dosages-of-acetaminophen-in-adults-and-children |website=Medscape |access-date=19 December 2018 |archive-date=21 December 2018 |archive-url= https://web.archive.org/web/20181221041534/https://www.medscape.com/answers/820200-27207/what-are-the-recommended-maximum-daily-dosages-of-acetaminophen-in-adults-and-children |url-status=live}}</ref><ref name="BMJ2015" /> Higher doses may lead to toxicity, including [[liver failure]].<ref name="AHFS2016">{{cite web| title=Acetaminophen| url=https://www.drugs.com/monograph/acetaminophen.html| publisher=The American Society of Health-System Pharmacists| access-date=16 September 2016| archive-url= https://web.archive.org/web/20160605063136/http://www.drugs.com/monograph/acetaminophen.html|archive-date=5 June 2016| url-status=live}}</ref> [[Paracetamol poisoning]] is the foremost cause of [[acute liver failure]] in the [[Western world]], and accounts for most drug overdoses in the United States, the United Kingdom, Australia, and New Zealand.<ref name="Daly2008">{{cite journal |vauthors=Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA |date=March 2008 |title=Guidelines for the management of paracetamol poisoning in Australia and New Zealand—explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres |journal=[[The Medical Journal of Australia]] |volume=188 |issue=5 |pages=296–301 |doi=10.5694/j.1326-5377.2008.tb01625.x |pmid=18312195 |s2cid=9505802}}</ref><ref name="Hawkins2007">{{cite journal |vauthors=Hawkins LC, Edwards JN, Dargan PI |year=2007 |title=Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature |journal=Drug Saf |volume=30 |issue=6 |pages=465–79 |doi=10.2165/00002018-200730060-00002 |pmid=17536874 |s2cid=36435353}}</ref><ref name="Larson2005">{{cite journal |vauthors=Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiødt FV, Ostapowicz G, Shakil AO, Lee WM, ((Acute Liver Failure Study Group)) |year=2005 |title=Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study |journal=Hepatology |volume=42 |issue=6 |pages=1364–72 |doi=10.1002/hep.20948 |pmid=16317692 |s2cid=24758491 |doi-access= |title-link=doi}}</ref>
 
<!-- Society and culture -->
Line 138 ⟶ 140:
 
====Dental and other post-surgical pain====
Pain after a dental surgery provides a reliable model for the action of analgesics on other kinds of acute pain.<ref name="pmid32027199">{{cite journal |vauthors=Pergolizzi JV, Magnusson P, LeQuang JA, Gharibo C, Varrassi G |title=The pharmacological management of dental pain |journal=Expert Opin Pharmacother |volume=21 |issue=5 |pages=591–601 |date=April 2020 |pmid=32027199 |doi=10.1080/14656566.2020.1718651 |s2cid=211046298}}</ref> For the relief of such pain, paracetamol is inferior to ibuprofen.<ref name= "pmid24338830">{{cite journal |vauthors=Bailey E, Worthington HV, van Wijk A, Yates JM, Coulthard P, Afzal Z |title=Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth |journal=Cochrane Database Syst Rev |volume= |issue=12 |pages=CD004624 |date=December 2013 |pmid=24338830 |doi= 10.1002/14651858.CD004624.pub2}}</ref> Full therapeutic doses of [[non-steroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug]]s (NSAIDs) ibuprofen, [[naproxen]] or [[diclofenac]] are clearly more efficacious than the [[Codeine/paracetamol|paracetamol/codeine]] combination which is frequently prescribed for dental pain.<ref name="pmid32286125">{{cite journal |vauthors=Hersh EV, Moore PA, Grosser T, Polomano RC, Farrar JT, Saraghi M, Juska SA, Mitchell CH, Theken KN |title=Nonsteroidal Anti-Inflammatory Drugs and Opioids in Postsurgical Dental Pain |journal=J Dent Res |volume=99 |issue=7 |pages=777–786 |date=July 2020 |pmid=32286125 |doi=10.1177/0022034520914254 |pmc=7313348 }}</ref> The combinations of paracetamol and NSAIDs ibuprofen or [[diclofenac]] are promising, possibly offering better pain control than either paracetamol or the NSAID alone.<ref name="pmid24338830"/><ref name="pmid23904576">{{cite journal |vauthors=Moore PA, Hersh EV |title=Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions: translating clinical research to dental practice |journal=J Am Dent Assoc |volume=144 |issue=8 |pages=898–908 |date=August 2013 |pmid=23904576 |doi=10.14219/jada.archive.2013.0207}}</ref><ref name="pmid23794268">{{cite journal |vauthors=Derry CJ, Derry S, Moore RA |title=Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain |journal=Cochrane Database Syst Rev |volume= 2019|issue=6 |pages=CD010210 |date=June 2013 |pmid=23794268 |pmc=6485825 |doi=10.1002/14651858.CD010210.pub2}}</ref><ref name="pmid30245281">{{cite journal |vauthors=Daniels SE, Atkinson HC, Stanescu I, Frampton C |title=Analgesic Efficacy of an Acetaminophen/Ibuprofen Fixed-dose Combination in Moderate to Severe Postoperative Dental Pain: A Randomized, Double-blind, Parallel-group, Placebo-controlled Trial |journal=Clin Ther |volume=40 |issue=10 |pages=1765–1776.e5 |date=October 2018 |pmid=30245281 |doi=10.1016/j.clinthera.2018.08.019 |doi-access=free |title-link = doi }}</ref> Additionally, the paracetamol/ibuprofen combination may be superior to paracetamol/codeine and ibuprofen/codeine combinations.<ref name="pmid23904576"/>
 
A meta-analysis of general post-surgical pain, which included dental and other surgery, showed the paracetamol/codeine combination to be more effective than paracetamol alone: it provided significant pain relief to as much as 53% of the participants, while the [[placebo]] helped only 7%.<ref name="pmid19160199">{{cite journal |vauthors= Toms L, Derry S, Moore RA, McQuay HJ |title=Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults |journal=Cochrane Database Syst Rev |volume= 2009|issue=1 |pages=CD001547 |date=January 2009 |pmid=19160199 |pmc=4171965 |doi=10.1002/14651858.CD001547.pub2}}</ref>
Line 144 ⟶ 146:
====Other pain====
 
Paracetamol fails to relieve procedural pain in [[newborn babies]].<ref name="pmid32257982">{{cite journal |vauthors=Allegaert K |title=A Critical Review on the Relevance of Paracetamol for Procedural Pain Management in Neonates |journal=Front Pediatr |volume=8 |issue= |pages=89 |date=2020 |pmid=32257982 |pmc=7093493 |doi= 10.3389/fped.2020.00089 |doi-access=free |title-link = doi }}</ref><ref>{{cite journal |vauthors = Ohlsson A, Shah PS |title = Paracetamol (acetaminophen) for prevention or treatment of pain in newborns |journal = The Cochrane Database of Systematic Reviews |volume = 1 |pages = CD011219 |date = January 2020 |issue = 1 |pmid = 31985830 |pmc = 6984663 |doi = 10.1002/14651858.CD011219.pub4 }}</ref> For [[perineum|perineal]] pain [[postpartum period|postpartum]] paracetamol appears to be less effective than [[non-steroidalNonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drugs]]s (NSAIDs).<ref name="pmid33427305">{{cite journal |vauthors=Wuytack F, Smith V, Cleary BJ |title=Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period |journal=Cochrane Database Syst Rev |volume=1 |issue= 1|pages=CD011352 |date=January 2021 |pmid=33427305 |doi= 10.1002/14651858.CD011352.pub3 |pmc=8092572}}</ref>
 
The studies to support or refute the use of paracetamol for cancer pain and for neuropathic pain are lacking.<ref name="pmid28700092">{{cite journal |vauthors=Wiffen PJ, Derry S, Moore RA, McNicol ED, Bell RF, Carr DB, McIntyre M, Wee B |title=Oral paracetamol (acetaminophen) for cancer pain |journal=Cochrane Database Syst Rev |volume=7 |issue= 2|pages=CD012637 |date=July 2017 |pmid=28700092 |pmc=6369932 |doi=10.1002/14651858.CD012637.pub2}}</ref><ref name="pmid28027389">{{cite journal |vauthors= Wiffen PJ, Knaggs R, Derry S, Cole P, Phillips T, Moore RA |title=Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults |journal=Cochrane Database Syst Rev |volume=12 |issue= 5|pages=CD012227 |date=December 2016 |pmid=28027389 |pmc=6463878 |doi=10.1002/14651858.CD012227.pub2}}</ref> There is limited evidence in favor of the use of the intravenous form of paracetamol for acute pain control in the emergency department.<ref>{{cite journal |vauthors = Sin B, Wai M, Tatunchak T, Motov SM |title = The Use of Intravenous Acetaminophen for Acute Pain in the Emergency Department |journal = Academic Emergency Medicine |volume = 23 |issue = 5 |pages = 543–53 |date = May 2016 |pmid = 26824905 |doi = 10.1111/acem.12921 |doi-access = free |title-link = doi }}</ref> The combination of paracetamol with caffeine is superior to paracetamol alone for the treatment of acute pain.<ref>{{cite journal |vauthors = Derry CJ, Derry S, Moore RA |title = Caffeine as an analgesic adjuvant for acute pain in adults |journal = The Cochrane Database of Systematic Reviews |volume = 3 |issue = 3 |pages = CD009281 |date = March 2012 |pmid = 22419343 |doi = 10.1002/14651858.CD009281.pub2 |s2cid = 205199173 |veditors = Derry S }}</ref>
Line 152 ⟶ 154:
 
==Adverse effects==
Gastrointestinal adverse effects such as nausea and [[abdominal pain]] are extremely uncommon, and their frequency is nothing
Gastrointestinal adverse effects such as nausea and [[abdominal pain]] are common, and their frequency is similar tolike that of [[ibuprofen]].<ref name="pmid31073920"/> Increase in risk-taking behavior is possible.<ref>{{cite journal |vauthors=Keaveney A, Peters E, Way B |title=Effects of acetaminophen on risk taking |journal=Social Cognitive and Affective Neuroscience |volume=15 |issue=7 |pages=725–732 |date=September 2020 |pmid=32888031 |pmc=7511878 |doi=10.1093/scan/nsaa108}}</ref> According to the USU.S. [[Food and Drug Administration]] (FDA), the drug may cause rare and possibly fatal skin reactions such as [[Stevens–Johnson syndrome]] and [[toxic epidermal necrolysis]],<ref name=":1">{{cite web |title=FDA Drug Safety Communication: FDA warns of rare but serious skin reactions with the pain reliever/fever reducer acetaminophen |website=U.S. [[Food and Drug Administration]] (FDA) |date=1 August 2013 |url=https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-skin-reactions-pain-relieverfever-reducer |archive-url= https://web.archive.org/web/20191028034057/https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-serious-skin-reactions-pain-relieverfever-reducer |archive-date=28 October 2019 |url-status=live |access-date=27 October 2019}} {{PD-notice}}</ref> [[Rechallenge]] tests and an analysis of American but not French [[pharmacovigilance]] databases indicated a risk of these reactions.<ref name=":1" /><ref name="pmid28963996">{{cite journal |vauthors=Lebrun-Vignes B, Guy C, Jean-Pastor MJ, Gras-Champel V, Zenut M |title=Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database |journal=Br J Clin Pharmacol |volume=84 |issue=2 |pages=331–338 |date=February 2018 |pmid=28963996 |pmc=5777438 |doi=10.1111/bcp.13445}}</ref>
 
In clinical trials for [[osteoarthritis]], the number of participants reporting adverse effects was similar for those on paracetamol and on [[placebo]]. However, the [[Elevated transaminases|abnormal liver function tests]] (meaning there was some inflammation or damage to the liver) were almost four times more likely in those on paracetamol, although the clinical importance of this effect is uncertain.<ref name="pmid30801133">{{cite journal |vauthors=Leopoldino AO, Machado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ, Hunter DJ, Ferreira ML |title=Paracetamol versus placebo for knee and hip osteoarthritis |journal=Cochrane Database Syst Rev |volume=2 |issue= 8|pages=CD013273 |date=February 2019 |pmid=30801133 |pmc=6388567 |doi=10.1002/14651858.CD013273}}</ref> After 13 weeks of paracetamol therapy for knee pain, a drop in [[hemoglobin]] level indicating [[gastrointestinal bleeding]] was observed in 20% of participants, this rate being similar to the ibuprofen group.<ref name="pmid25732175">{{cite journal |vauthors=Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, Doherty M, Zhang W, Birrell F, Porcheret M, Dziedzic K, Bernstein I, Wise E, Conaghan PG |title=Paracetamol: not as safe as we thought? A systematic literature review of observational studies |journal=Ann Rheum Dis |volume=75 |issue=3 |pages=552–9 |date=March 2016 |pmid=25732175 |pmc=4789700 |doi=10.1136/annrheumdis-2014-206914}}</ref>
Line 162 ⟶ 165:
In recommended doses, the [[Side effect|side effects]] of paracetamol are mild to non-existent.<ref name="PM: FBtCP">{{cite book |last=Hughes |first=John |title=Pain Management: From Basics to Clinical Practice |publisher=Elsevier Health Sciences |year=2008 |isbn=9780443103360}}</ref> In contrast to aspirin, it is not a [[Antiplatelet drug|blood thinner]] (and thus may be used in patients where bleeding is a concern), and it does not cause gastric irritation.<ref name="TCD">{{cite book |last=Sarg |first=Michael |title=The Cancer Dictionary |author2=Ann D Gross |author3=Roberta Altman |publisher=Infobase Publishing |year=2007 |isbn=978081606-4113}}</ref> Compared to [[Ibuprofen]]—which can have adverse effects that include diarrhea, vomiting, and abdominal pain—paracetamol is well tolerated with fewer side effects.<ref>{{cite journal |last=Ebrahimi |first=Sedigheh |author2=Soheil Ashkani Esfahani |author3=Hamid Reza Ghaffarian |author4=Mahsima Khoshneviszade |year=2010 |title=Comparison of efficacy and safety of acetaminophen and ibuprofen administration as single dose to reduce fever in children. |url=http://journals.tums.ac.ir/abs/17188 |url-status=dead |journal=Iranian Journal of Pediatrics |volume=20 |issue=4 |pages=500–501 |archive-url=https://archive.today/20120709124051/http://journals.tums.ac.ir/abs/17188 |archive-date=2012-07-09}}</ref> Prolonged daily use and may cause kidney or liver damage.<ref name="TCD" /><ref>{{cite news |date=November 23, 2003 |title=Painkillers 'cause kidney damage' |url=http://news.bbc.co.uk/2/hi/health/3271191.stm |access-date=March 27, 2010 |work=BBC News}}</ref>Paracetamol is metabolized by the liver and is [[hepatotoxic]]; side effects may be more likely in [[Alcoholism|chronic alcoholics]] or patients with liver damage.<ref name="PM: FBtCP" /><ref>{{cite book |last=Dukes |first=MNG |title=Meyler's Side Effects of Drugs, Vol XIV |author2=Jeffrey K Aronson |publisher=Elsevier |year=2000 |isbn=9780444500939}}</ref>
 
Until 2010 paracetamol was believed safe in pregnancy however, in a study published in October 2010 it has been linked to [[infertility]] in the adult life of the unborn.<ref>{{cite journal |author=Leffers, H |display-authors=etal |year=2010 |title=Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat |journal=Human Reproduction |volume=25 |issue=1 |pages=235–244 |doi=10.1093/humrep/deq382 |doi-access=free}}</ref> Like NSAIDs and unlike opioid analgesics, paracetamol has not been found to cause euphoria or alter mood. althoughOne recent research showsstudy has showed some evidence that paracetamol can ease psychological pain, but more studies are needed to draw an informed conclusion.<ref>{{cite web |date=16 July 2014 |title=Could Tylenol Ease Emotional Pain? |url=http://www.evergreen-magazine.com/2014/07/tylenol-ease-emotional-pain/ |url-status=dead |archive-url=https://web.archive.org/web/20140819090402/http://www.evergreen-magazine.com/2014/07/tylenol-ease-emotional-pain/ |archive-date=19 August 2014 |access-date=17 August 2014 |publisher=Evergreen Magazine}}</ref> Unlike aspirin, it is safe for children, as paracetamol is not associated with a risk of [[Reye's syndrome]] in children with viral illnesses.<ref>{{cite journal |vauthors=Lesko SM, Mitchell AA |year=1999 |title=The safety of acetaminophen and ibuprofen among children younger than two years old |journal=Pediatrics |volume=104 |issue=4 |pages=e39 |doi=10.1542/peds.104.4.e39 |pmid=10506264 |s2cid=3107281 |doi-access=free}}</ref> Chronic users of paracetamol may have a higher risk of developing [[Hematological malignancy|blood cancer]].<ref>{{cite journal |author1=Roland B. Walter |author2=Filippo Milano |author3=Theodore M. Brasky |author4=Emily White |year=2011 |title=Long-Term Use of Acetaminophen, Aspirin, and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Hematologic Malignancies: Results From the Prospective Vitamins and Lifestyle (VITAL) Study |journal=Journal of Clinical Oncology |volume=29 |issue=17 |pages=2424–31 |doi=10.1200/JCO.2011.34.6346 |pmc=3107756 |pmid=21555699}}</ref>
 
===Use in pregnancy===
Paracetamol safety in pregnancy has been under increased scrutiny. There appears to be no link between paracetamol use in the first trimester and adverse pregnancy outcomes or [[birth defects]]. However, indications exist of a possible increase of asthma and developmental and reproductive disorders in the offspring of women with prolonged use of paracetamol during pregnancy.<ref name="pmid29863746"/>
 
Paracetamol use by the mother during pregnancy is associated with an increased risk of childhood [[asthma]],<ref>{{cite journal| vauthors=Eyers S, Weatherall M, Jefferies S, Beasley R |title=Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis|journal=Clinical and Experimental Allergy |date= April 2011|volume=41|issue=4|pages=482–9|pmid=21338428|doi=10.1111/j.1365-2222.2010.03691.x |s2cid=205275267}}</ref><ref name="pmid28237129">{{cite journal |vauthors=Fan G, Wang B, Liu C, Li D |title=Prenatal paracetamol use and asthma in childhood: A systematic review and meta-analysis |journal=Allergol Immunopathol (Madr) |volume=45 |issue=6 |pages=528–533 |date=2017 |pmid=28237129 |doi=10.1016/j.aller.2016.10.014}}</ref> but so are the maternal infections for which paracetamol may be used, and separating these influences is difficult.<ref name="pmid29863746"/> Paracetamol, in a small scale meta-analysis was also associated with a 20{{ndash}}30% increase in [[autism spectrum disorder]], [[attention deficit hyperactivity disorder]], hyperactivity symptoms, and [[conduct disorder]], with the association being lower in a meta-analysis where a larger demographic was used, but it is unclear whether this is a causal relationship and there was potential bias in the findings.<ref name="pmid29863746"/><ref name="pmid29688261">{{cite journal |vauthors=Masarwa R, Levine H, Gorelik E, Reif S, Perlman A, Matok I |title= Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies |journal=Am J Epidemiol |volume=187 |issue=8 |pages=1817–1827 |date=August 2018 |pmid=29688261 |doi=10.1093/aje/kwy086 |doi-access= free |title-link = doi }}</ref><ref name="pmid31664451">{{cite journal |vauthors=Ji Y, Azuine RE, Zhang Y, Hou W, Hong X, Wang G, Riley A, Pearson C, Zuckerman B, Wang X |title= Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood |journal=JAMA Psychiatry |volume=77 |issue=2 |pages=180–189 |date=February 2020 |pmid=31664451 |pmc=6822099 |doi=10.1001/jamapsychiatry.2019.3259}}</ref> There is also an argument that the large number, consistency, and the robust designs of the studies provide a strong evidence in favor of paracetamol causing the increased risk of these neurodevelopmental disorders.<ref name="pmid29341895">{{cite journal |vauthors=Bauer AZ, Kriebel D, Herbert MR, Bornehag CG, Swan SH |title=Prenatal paracetamol exposure and child neurodevelopment: A review |journal=Horm Behav |volume=101 |issue= |pages=125–147 |date=May 2018 |pmid=29341895 |doi=10.1016/j.yhbeh.2018.01.003 |s2cid=4822468}}</ref><ref name="pmid30654621">{{cite journal |vauthors=Gou X, Wang Y, Tang Y, Qu Y, Tang J, Shi J, Xiao D, Mu D |title=Association of maternal prenatal acetaminophen use with the risk of attention deficit/hyperactivity disorder in offspring: A meta-analysis |journal=Aust N Z J Psychiatry |volume=53 |issue=3 |pages=195–206 |date=March 2019 |pmid= 30654621 |doi=10.1177/0004867418823276 |s2cid=58575048}}</ref> In animal experiments, paracetamol disrupts fetal [[testosterone]] production, and several epidemiological studies linked [[cryptorchidism]] with mother's paracetamol use for more than two weeks in the second trimester. On the other hand, several studies did not find any association.<ref name="pmid29863746"/>
 
The consensus recommendation appears to be to avoid prolonged use of paracetamol in pregnancy and use it only when necessary, at the lowest effective dosage and for the shortest time.<ref name="pmid29863746"/><ref name="pmid28986045">{{cite journal |vauthors=Toda K |title=Is acetaminophen safe in pregnancy? |journal=Scand J Pain |volume=17 |issue= |pages=445–446 |date=October 2017 |pmid=28986045 |doi=10.1016/j.sjpain.2017.09.007 |s2cid=205183310}}</ref><ref name="pmid31242344">{{cite journal |vauthors=Black E, Khor KE, Kennedy D, Chutatape A, Sharma S, Vancaillie T, Demirkol A |title=Medication Use and Pain Management in Pregnancy: A Critical Review |journal=Pain Pract |volume=19 |issue=8 |pages=875–899 |date=November 2019 |pmid=31242344 |doi=10.1111/papr.12814 |s2cid=195694287}}</ref>
 
In pregnancy, acetaminophenparacetamol and [[metoclopramide]] are deemed safe as are NSAIDs until the [[third trimester]].<ref name="Gilmore2011">{{cite journal |last=Gilmore |first=B |author2=Michael, M |date=2011-02-01 |title=Treatment of acute migraine headache. |journal=American Family Physician |volume=83 |issue=3 |pages=271–80 |pmid=21302868}}</ref>
 
==Overdose==
Line 177 ⟶ 180:
[[Drug overdose|Overdose]] of paracetamol is caused by taking more than the recommended maximum daily dose of paracetamol for healthy adults (three or four grams),<ref name=UK2017/><ref name=Med2018/> and can cause potentially fatal [[Hepatotoxicity|liver damage]].<ref>{{cite web |title=Acetaminophen Information |website=U.S. [[Food and Drug Administration]] |date=14 November 2017 |url=https://www.fda.gov/drugs/information-drug-class/acetaminophen-information |archive-url= https://web.archive.org/web/20191028022254/https://www.fda.gov/drugs/information-drug-class/acetaminophen-information |archive-date=28 October 2019 |url-status=live |access-date=27 October 2019}}{{PD-notice}}</ref><ref>{{cite web |title=Using Acetaminophen and Nonsteroidal Anti-inflammatory Drugs Safely |website=U.S. [[Food and Drug Administration]] (FDA) |date=26 February 2018 |url=https://www.fda.gov/drugs/safe-use-over-counter-pain-relievers-and-fever-reducers/using-acetaminophen-and-nonsteroidal-anti-inflammatory-drugs-safely |archive-url=https://web.archive.org/web/20191028025936/https://www.fda.gov/drugs/safe-use-over-counter-pain-relievers-and-fever-reducers/using-acetaminophen-and-nonsteroidal-anti-inflammatory-drugs-safely |archive-date=28 October 2019 |url-status=live |access-date=27 October 2019}}{{PD-notice}}</ref> A single dose should not exceed 1000&nbsp;mg, doses should be taken no sooner than four hours apart, and no more than four doses (4000&nbsp;mg) in 24 hours.<ref name=UK2017/> While a majority of adult overdoses are linked to suicide attempts, many cases are accidental, often due to the use of more than one paracetamol-containing product over an extended period.<ref>{{cite journal | vauthors = Amar PJ, Schiff ER | title = Acetaminophen safety and hepatotoxicity--where do we go from here? | journal = Expert Opinion on Drug Safety | volume = 6 | issue = 4 | pages = 341–355 | date = July 2007 | pmid = 17688378 | doi = 10.1517/14740338.6.4.341 | s2cid = 20399748 }}</ref>
 
[[Paracetamol toxicity]] has become the foremost cause of [[acute liver failure]] in the [[United States]] by 2003,<ref name="Larson2005" /> and {{As of|2005|lc=y}}, paracetamol accounted for most drug overdoses in the United States, the United Kingdom, Australia, and New Zealand.<ref>{{cite journal | vauthors = Buckley N, Eddleston M | title = Paracetamol (acetaminophen) poisoning | journal = Clinical Evidence | issue = 14 | pages = 1738–1744 | date = December 2005 | pmid = 16620471 | url = https://pubmed.ncbi.nlm.nih.gov/16620471/ }}</ref> As of 2004, paracetamol overdose resulted in more calls to [[poison control center]]s in the USU.S. than overdose of any other pharmacological substance.<ref name="Lee2004">{{cite journal |vauthors=Lee WM |title=Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure |journal=Hepatology |volume=40 |issue=1 |pages=6–9 |year=2004 |pmid=15239078 |doi=10.1002/hep.20293|s2cid=15485538 |doi-access=free |title-link = doi }}</ref> According to the FDA, in the United States, "56,000 emergency room visits, 26,000 hospitalizations, and 458 deaths per year [were] related to acetaminophen-associated overdoses during the 1990s. Within these estimates, unintentional acetaminophen overdose accounted for nearly 25% of the emergency department visits, 10% of the hospitalizations, and 25% of the deaths."<ref>{{cite web| publisher=US Food and Drug Administration| date=14 January 2011| website=regulations.gov| url=http://www.regulations.gov/#!documentDetail;D=FDA-2011-N-0021-0001 |title=Prescription Drug Products Containing Acetaminophen: Actions to Reduce Liver Injury from Unintentional Overdose| archive-url=https://web.archive.org/web/20120925153342/http://www.regulations.gov/ |archive-date=25 September 2012 |access-date=23 February 2014}}{{PD-notice}}</ref>{{needs update|date=February 2024}}
 
Overdoses are frequently related to high-dose [[Recreational drug use|recreational use]] of prescription [[opioids]], as these opioids are most often combined with paracetamol.<ref>{{cite news |url=https://www.cnn.com/2014/01/15/health/fda-acetaminophen-dosage/index.html |vauthors=Yan H |title=FDA: Acetaminophen doses over 325 mg may lead to liver damage |publisher=[[CNN]] |access-date=18 February 2014 |date=16 January 2014 |url-status=live |archive-url= https://web.archive.org/web/20140216091112/http://www.cnn.com/2014/01/15/health/fda-acetaminophen-dosage/index.html?hpt=hp_t2 |archive-date=16 February 2014}}</ref> The overdose risk may be heightened by frequent consumption of alcohol.<ref name="Lee2017">{{cite journal |vauthors=Lee WM |title=Acetaminophen (APAP) hepatotoxicity—Isn't it time for APAP to go away? |journal=Journal of Hepatology |volume=67 |issue=6 |pages=1324–1331 |date=December 2017 |pmid=28734939 |pmc=5696016 |doi=10.1016/j.jhep.2017.07.005}}</ref>
Line 200 ⟶ 203:
===Pharmacodynamics===
 
Paracetamol appears to exert its effects through two mechanisms: the inhibition of [[cyclooxygenase]] (COX) and actions of its metabolite [[N-arachidonoylphenolamine]] (AM404).<ref name=Ghanem2016>{{cite journal |vauthors = Ghanem CI, Pérez MJ, Manautou JE, Mottino AD |title = Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity |journal = Pharmacological Research |volume = 109 |pages = 119–31 |date = July 2016 |pmid = 26921661 |pmc = 4912877 |doi = 10.1016/j.phrs.2016.02.020 }}</ref>
 
Supporting the first mechanism, pharmacologically and in its side effects, paracetamol is close to classical [[nonsteroidal anti-inflammatory drug]]s (NSAIDs) that act by inhibiting [[COX-1]] and [[COX-2]] enzymes and especially similar to selective [[COX-2 inhibitor]]s.<ref name="pmid23719833">{{cite journal |vauthors=Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF |title=The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings |journal=Inflammopharmacology |volume=21 |issue=3 |pages=201–32 |date=June 2013 |pmid=23719833 |doi=10.1007/s10787-013-0172-x |s2cid=11359488}}</ref> Paracetamol inhibits [[prostaglandin]] synthesis by [[Reduction (chemistry)|reducing]] the active form of COX-1 and COX-2 enzymes. This occurs only when the concentration of [[arachidonic acid]] and [[Organic peroxide#Biology|peroxides]] is low. Under these conditions, COX-2 is the predominant form of cyclooxygenase, which explains the apparent COX-2 selectivity of paracetamol. Under the conditions of inflammation, the concentration of peroxides is high, which counteracts the reducing effect of paracetamol. Accordingly, the anti-inflammatory action of paracetamol is slight.<ref name=Ghanem2016/><ref name="pmid23719833"/> The anti-inflammatory action of paracetamol (via COX inhibition) has also been found to primarily target the [[central nervous system]] and not peripheral areas of the body, explaining the lack of side effects associated with conventional NSAIDs such as gastric bleeding.
 
The second mechanism centers on the paracetamol metabolite [[AM404]]. This metabolite has been detected in the brains of animals and [[cerebrospinal fluid]] of humans taking paracetamol.<ref name=Ghanem2016/><ref name="pmid29238213">{{cite journal |vauthors=Sharma CV, Long JH, Shah S, Rahman J, Perrett D, Ayoub SS, Mehta V |title=First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid |journal=J Pain Res |volume=10 |issue= |pages=2703–2709 |date=2017 |pmid=29238213 |pmc=5716395 |doi=10.2147/JPR.S143500 |doi-access=free }}</ref> It is formed in the brain from another paracetamol metabolite [[4-aminophenol]] by action of [[fatty acid amide hydrolase]].<ref name=Ghanem2016/> AM404 is a weak agonist of cannabinoid receptors [[Cannabinoid receptor type 1|CB1]] and [[Cannabinoid receptor type 2|CB2]], an inhibitor of [[endocannabinoid transporter]], and a potent activator of [[TRPV1]] receptor.<ref name=Ghanem2016/> This and other research indicate that the [[Endocannabinoid system|cannabinoidendocannabinoid system]] and TRPV1 may play an important role in the analgesic effect of paracetamol.<ref name=Ghanem2016/><ref name="pmid33328986">{{cite journal |vauthors=Ohashi N, Kohno T |title=Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action |journal=Front Pharmacol |volume=11 |issue= |pages=580289 |date=2020 |pmid=33328986 |pmc=7734311 |doi=10.3389/fphar.2020.580289 |doi-access=free |title-link = doi }}</ref>
 
In 2018, Suemaru ''et al''. found that, in mice, paracetamol exerts an anticonvulsant effect by activation of the [[TRPV1]] receptors<ref name="Suemaru2018">{{cite journal |vauthors = Suemaru K, Yoshikawa M, Aso H, Watanabe M |title = TRPV1 mediates the anticonvulsant effects of acetaminophen in mice |journal = Epilepsy Research |volume = 145 |pages = 153–159 |date = September 2018 |pmid = 30007240 |doi = 10.1016/j.eplepsyres.2018.06.016 |s2cid = 51652230 }}</ref> and a decrease in neuronal excitability by [[Hyperpolarization (biology)|hyperpolarization]] of neurons.<ref>{{cite journal |vauthors = Ray S, Salzer I, Kronschläger MT, Boehm S |title = The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on KV7 channels |journal = Pain |volume = 160 |issue = 4 |pages = 954–964 |date = April 2019 |pmid = 30601242 |pmc = 6430418 |doi = 10.1097/j.pain.0000000000001474 }}</ref> The exact mechanism of the anticonvulsant effect of acetaminophen is not clear. According to Suemaru ''et al''., acetaminophen and its active metabolite [[AM404]] show a dose-dependent anticonvulsant activity against pentylenetetrazol-induced seizures in mice.<ref name="Suemaru2018" />
Line 249 ⟶ 252:
Von Mering's claims remained essentially unchallenged for half a century, until two teams of researchers from the United States analyzed the metabolism of acetanilide and phenacetin.<ref name=drugdiscov/> In 1947, [[David Lester (biochemist)|David Lester]] and Leon Greenberg found strong evidence that paracetamol was a major metabolite of acetanilide in human blood, and in a subsequent study they reported that large doses of paracetamol given to albino rats did not cause methemoglobinemia.<ref>{{cite journal|vauthors = Lester D, Greenberg LA, Carroll RP|title = The metabolic fate of acetanilid and other aniline derivatives: II. Major metabolites of acetanilid appearing in the blood|journal = J. Pharmacol. Exp. Ther.|year = 1947|volume = 90|pages = 68–75|url = http://jpet.aspetjournals.org/cgi/reprint/90/1/68|pmid = 20241897|issue = 1|url-status=live|archive-url = https://web.archive.org/web/20081202161015/http://jpet.aspetjournals.org/cgi/reprint/90/1/68|archive-date = 2 December 2008}}</ref> In 1948, [[Bernard Brodie (biochemist)|Bernard Brodie]], [[Julius Axelrod]] and Frederick Flinn confirmed that paracetamol was the major metabolite of acetanilide in humans, and established that it was just as efficacious an analgesic as its precursor.<ref>{{cite journal| vauthors=Brodie BB, Axelrod J |author-link2=Julius Axelrod |title = The estimation of acetanilide and its metabolic products, aniline, ''N''-acetyl ''p''-aminophenol and ''p''-aminophenol (free and total conjugated) in biological fluids and tissues|journal = J. Pharmacol. Exp. Ther.|year = 1948|volume = 94|issue = 1|pages = 22–28|pmid = 18885610}}</ref><ref>{{cite journal | vauthors = Brodie BB, Axelrod J | author-link2 = Julius Axelrod | title = The fate of acetanilide in man | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 94 | issue = 1 | pages = 29–38 | date = September 1948 | pmid = 18885611 | url = http://profiles.nlm.nih.gov/HH/A/A/A/D/_/hhaaad.pdf | url-status = live | archive-url = https://web.archive.org/web/20080907110847/http://profiles.nlm.nih.gov/HH/A/A/A/D/_/hhaaad.pdf | archive-date = 7 September 2008 }}</ref><ref>{{cite journal| vauthors=Flinn FB, Brodie BB |title = The effect on the pain threshold of ''N''-acetyl ''p''-aminophenol, a product derived in the body from acetanilide|journal = J. Pharmacol. Exp. Ther.|year = 1948|volume = 94|issue = 1|pages = 76–77|pmid = 18885618}}</ref> They also suggested that methemoglobinemia is produced in humans mainly by another metabolite, [[phenylhydroxylamine]]. A follow-up paper by Brodie and Axelrod in 1949 established that phenacetin was also metabolized to paracetamol.<ref>{{cite journal | vauthors = Brodie BB, Axelrod J | title = The fate of acetophenetidin in man and methods for the estimation of acetophenetidin and its metabolites in biological material | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 97 | issue = 1 | pages = 58–67 | date = September 1949 | pmid = 18140117 | url = https://jpet.aspetjournals.org/content/97/1/58 }}</ref> This led to a "rediscovery" of paracetamol.<ref name=Bertolini2006rev/>
 
Paracetamol was first marketed in the United States in 1950 under the name TriagesicTrigesic, a combination of paracetamol, [[aspirin]], and caffeine.<ref name=badmed/> Reports in 1951 of three users stricken with the blood disease [[agranulocytosis]] led to its removal from the marketplace, and it took several years until it became clear that the disease was unconnected.<ref name=badmed/> The following year, 1952, paracetamol returned to the USU.S. market as a prescription drug.<ref name="pmid329728"/> In the United Kingdom, marketing of paracetamol began in 1956 by [[Sterling-Winthrop Co.]] as Panadol, available only by prescription, and promoted as preferable to aspirin since it was safe for children and people with ulcers.<ref name="pmid799998">{{cite journal |vauthors=Spooner JB, Harvey JG |title=The history and usage of paracetamol |journal=J Int Med Res |volume=4 |issue=4 Suppl |pages=1–6 |date=1976 |pmid=799998 |doi=10.1177/14732300760040S403 |s2cid=11289061}}</ref><ref name="LandauAchilladelis1999">{{cite book| vauthors = Landau R, Achilladelis B, Scriabine A |title=Pharmaceutical Innovation: Revolutionizing Human Health|url=https://books.google.com/books?id=IH4lPs6S1bMC&pg=PA248|year=1999|publisher=Chemical Heritage Foundation|isbn=978-0-941901-21-5|pages=248–249|url-status=live|archive-url= https://web.archive.org/web/20160817194009/https://books.google.com/books?id=IH4lPs6S1bMC&pg=PA248|archive-date=17 August 2016 }}</ref> In 1963, paracetamol was added to the ''[[British Pharmacopoeia]]'', and has gained popularity since then as an analgesic agent with few side-effects and little interaction with other pharmaceutical agents.<ref name="pmid799998"/><ref name=badmed>{{cite book|title=Bad Medicine: The Prescription Drug Industry in the Third World |vauthors = Silverman M, Lydecker M, Lee PR |publisher= Stanford University Press |year=1992 |isbn=978-0804716697 |pages=[https://archive.org/details/badmedicinepresc0000silv/page/88 88]–90 |url= https://archive.org/details/badmedicinepresc0000silv |url-access=registration}}</ref>
 
Concerns about paracetamol's safety delayed its widespread acceptance until the 1970s, but in the 1980s paracetamol sales exceeded those of aspirin in many countries, including the United Kingdom. This was accompanied by the commercial demise of phenacetin, blamed as the cause of [[analgesic nephropathy]] and hematological toxicity.<ref name=Bertolini2006rev/> Available in the USU.S. [[Over-the-counter drug|without a prescription]] since 1955<ref name="pmid329728">{{cite journal |vauthors=Ameer B, Greenblatt DJ |title=Acetaminophen |journal=Ann Intern Med |volume=87 |issue=2 |pages=202–9 |date=August 1977 |pmid=329728 |doi=10.7326/0003-4819-87-2-202}}</ref> (1960, according to another source<ref>{{cite web |url=http://www.tylenol.com/news/about-us |title=Our Story |publisher=McNEIL-PPC, Inc. |access-date=8 March 2014 |url-status=dead |archive-url=https://web.archive.org/web/20140308090216/http://www.tylenol.com/news/about-us |archive-date=8 March 2014 }}</ref>), paracetamol has become a common household drug.<ref>{{cite news |url=http://www.medicinenet.com/acetaminophen/article.htm |title=Medication and Drugs |date=1996–2010 |work=MedicineNet |access-date=22 April 2010 |url-status=live |archive-url=https://web.archive.org/web/20100422200526/http://www.medicinenet.com/acetaminophen/article.htm |archive-date=22 April 2010}}</ref> In 1988, [[Sterling Winthrop]] was acquired by [[Eastman Kodak]] which sold the over the counter drug rights to [[SmithKline Beecham]] in 1994.<ref>{{cite web| url=http://www.secinfo.com/dUGc.bs.htm |title=SEC Info – Eastman Kodak Co – '8-K' for 6/30/94 |access-date=3 March 2016|url-status=dead|archive-url= https://web.archive.org/web/20160304061947/http://www.secinfo.com/dUGc.bs.htm|archive-date=4 March 2016}}</ref>
 
In June 2009, an FDA advisory committee recommended that new restrictions be placed on paracetamol use in the United States to help protect people from the potential toxic effects. The maximum single adult dosage would be decreased from 1000{{nbsp}}mg to 650{{nbsp}}mg, while combinations of paracetamol and other products would be prohibited. Committee members were particularly concerned by the fact that the then-present maximum dosages of paracetamol had been shown to produce alterations in liver function.<ref name="WebMD">{{cite web |url=http://www.webmd.com/pain-management/news/20090701/fda-may-restrict-acetaminophen |title=FDA May Restrict Acetaminophen |publisher=Webmd |date=1 July 2009 |access-date=19 March 2011 |url-status=live |archive-url=https://web.archive.org/web/20110321075108/http://www.webmd.com/pain-management/news/20090701/fda-may-restrict-acetaminophen |archive-date=21 March 2011 }}</ref>
Line 271 ⟶ 274:
Paracetamol is available in oral, suppository, and [[intravenous]] forms.<ref>{{cite book |chapter = Acetaminophen |title=Physicians' Desk Reference |date= 2009 |publisher=Physicians' Desk Reference |location=Montvale, N.J. |isbn=978-1-56363-703-2 |oclc = 276871036 |edition=63rd |pages = 1915–1916 }}</ref> Intravenous paracetamol is sold under the brand name Ofirmev in the United States.<ref>{{cite web |vauthors = Nam S |title=IV, PO, and PR Acetaminophen: A Quick Comparison |url=https://www.pharmacytimes.com/contributor/stephanie-nam-pharmd-candidate-2017/2016/08/iv-po-and-pr-acetaminophen-a-quick-comparison |website=Pharmacy Times |access-date=24 October 2019 |archive-date=24 October 2019 |archive-url= https://web.archive.org/web/20191024195854/https://www.pharmacytimes.com/contributor/stephanie-nam-pharmd-candidate-2017/2016/08/iv-po-and-pr-acetaminophen-a-quick-comparison |url-status=dead }}</ref>
 
In some formulations, paracetamol is combined with the [[opiate]] [[codeine]], sometimes referred to as [[co-codamol]] ([[British Approved Name|BAN]]) and Panadeine in Australia. In the USU.S., this combination is available only by prescription.<ref>{{cite web |title=Acetaminophen and Codeine (Professional Patient Advice) |website=Drugs.com |date=29 June 2019 |url=https://www.drugs.com/ppa/acetaminophen-and-codeine.html |access-date=25 February 2020 |archive-date=20 May 2020 |archive-url=https://web.archive.org/web/20200520011658/https://www.drugs.com/ppa/acetaminophen-and-codeine.html |url-status=live }}</ref> As of 1 February 2018, medications containing codeine also became prescription-only in Australia.<ref>{{cite web|title=Codeine information hub|url=https://www.tga.gov.au/codeine-info-hub|url-status=live|access-date=9 December 2021|website=Therapeutic Goods Administration, Australian Government|date=10 April 2018|archive-date=8 December 2021|archive-url=https://web.archive.org/web/20211208232855/https://www.tga.gov.au/codeine-info-hub}}</ref> Paracetamol is also combined with other opioids such as [[dihydrocodeine]],<ref>{{cite web |title=Acetaminophen, Caffeine, and Dihydrocodeine (Professional Patient Advice) |website=Drugs.com |date=2 October 2019 |url=https://www.drugs.com/ppa/acetaminophen-caffeine-and-dihydrocodeine.html |access-date=25 February 2020 |archive-date=19 May 2020 |archive-url=https://web.archive.org/web/20200519154515/https://www.drugs.com/ppa/acetaminophen-caffeine-and-dihydrocodeine.html |url-status=live }}</ref> referred to as [[co-dydramol]] ([[British Approved Name]] (BAN)), [[oxycodone]]<ref>{{cite web |title=Oxycodone and Acetaminophen (Professional Patient Advice) |website=Drugs.com |date=11 November 2019 |url=https://www.drugs.com/ppa/oxycodone-and-acetaminophen.html |access-date=25 February 2020 |archive-date=20 May 2020 |archive-url= https://web.archive.org/web/20200520113856/https://www.drugs.com/ppa/oxycodone-and-acetaminophen.html |url-status=live }}</ref> or [[hydrocodone]].<ref>{{cite web |title= Hydrocodone and Acetaminophen (Professional Patient Advice) |website=Drugs.com |date=2 January 2020 |url=https://www.drugs.com/ppa/hydrocodone-and-acetaminophen.html |access-date=25 February 2020 |archive-date=21 May 2020 |archive-url=https://web.archive.org/web/20200521011245/https://www.drugs.com/ppa/hydrocodone-and-acetaminophen.html |url-status=live }}</ref> Another very commonly used analgesic combination includes paracetamol in combination with [[propoxyphene napsylate]].<ref>{{cite web |title=Propoxyphene and Acetaminophen Tablets |website=Drugs.com |date=21 June 2019 |url=https://www.drugs.com/pro/propoxyphene-and-acetaminophen-tablets.html |access-date=25 February 2020 |archive-date=20 May 2020 |archive-url=https://web.archive.org/web/20200520023253/https://www.drugs.com/pro/propoxyphene-and-acetaminophen-tablets.html |url-status=live }}</ref> A combination of paracetamol, codeine, and the [[doxylamine|doxylamine succinate]] is also available.<ref>{{cite web |title=APOHealth Paracetamol Plus Codeine & Calmative |website=Drugs.com |date=3 February 2020 |url=https://www.drugs.com/international/apohealth-paracetamol-plus-codeine-calmative.html |access-date=25 February 2020 |archive-date=25 February 2020 |archive-url= https://web.archive.org/web/20200225175247/https://www.drugs.com/international/apohealth-paracetamol-plus-codeine-calmative.html |url-status=live }}</ref>
 
Paracetamol is sometimes combined with [[phenylephrine hydrochloride]].<ref name="AtkinsonStanescu2014">{{cite journal| vauthors=Atkinson HC, Stanescu I, Anderson BJ |title=Increased Phenylephrine Plasma Levels with Administration of Acetaminophen|journal=New England Journal of Medicine|volume=370|issue=12|year=2014|pages=1171–1172|doi=10.1056/NEJMc1313942|pmid=24645960|doi-access=free|hdl=2292/34799|hdl-access=free}}</ref> Sometimes a third active ingredient, such as [[ascorbic acid]],<ref name="AtkinsonStanescu2014"/><ref>{{cite web |url=http://www.nhs.uk/medicine-guides/pages/selectorshow.aspx?medicine=Ascorbic%20acid/Phenylephrine/Paracetamol |publisher=[[National Health Service]] |work=NHS Choices |title= Ascorbic acid/Phenylephrine/Paracetamol |access-date=25 March 2014 |url-status=dead |archive-url= https://web.archive.org/web/20140326001907/http://www.nhs.uk/medicine-guides/pages/selectorshow.aspx?medicine=Ascorbic%20acid%2FPhenylephrine%2FParacetamol |archive-date=26 March 2014}}</ref> [[caffeine]],<ref>{{cite web |url=http://www.nhs.uk/medicine-guides/pages/MedicineOverview.aspx?medicine=Phenylephrine/Caffeine/Paracetamol%20dual%20relief |title=Phenylephrine/Caffeine/Paracetamol dual relief |publisher=[[National Health Service]] |work=NHS Choices |access-date=25 March 2014 |url-status=dead |archive-url=https://web.archive.org/web/20140326003729/http://www.nhs.uk/medicine-guides/pages/MedicineOverview.aspx?medicine=Phenylephrine%2FCaffeine%2FParacetamol%20dual%20relief |archive-date=26 March 2014}}</ref><ref>{{cite web |url= http://www.nhs.uk/Conditions/Painkillers-paracetamol/Pages/MedicineOverview.aspx?medicine=Beechams%20Decongestant%20Plus%20With%20Paracetamol |title=Beechams Decongestant Plus With Paracetamol |publisher=[[National Health Service]] |work=NHS Choices |access-date=25 March 2014 |url-status=dead |archive-url= https://web.archive.org/web/20140326001905/http://www.nhs.uk/Conditions/Painkillers-paracetamol/Pages/MedicineOverview.aspx?medicine=Beechams%20Decongestant%20Plus%20With%20Paracetamol |archive-date=26 March 2014}}</ref> [[Chlorphenamine|chlorpheniramine maleate]],<ref name="SenyuvaOzden2002">{{cite journal| vauthors=Senyuva H, Ozden T |title=Simultaneous High-Performance Liquid Chromatographic Determination of Paracetamol, Phenylephrine HCl, and Chlorpheniramine Maleate in Pharmaceutical Dosage Forms|journal=Journal of Chromatographic Science|volume=40|issue=2|year=2002|pages=97–100| doi= 10.1093/chromsci/40.2.97|pmid=11881712|doi-access=free |title-link = doi }}</ref> or [[guaifenesin]]<ref name="JaninMonnet2014">{{cite journal| vauthors=Janin A, Monnet J |title= Bioavailability of paracetamol, phenylephrine hydrochloride and guaifenesin in a fixed-combination syrup versus an oral reference product|journal=Journal of International Medical Research|volume=42|issue=2|year=2014|pages=347–359|doi=10.1177/0300060513503762|pmid= 24553480|doi-access=free |title-link = doi }}</ref><ref>{{cite web |title=Paracetamol – phenylephrine hydrochloride – guaifenesin |work=NPS MedicineWise |publisher=National Prescribing Service (Australia) |url=http://www.nps.org.au/medicines/respiratory-system/cough-and-cold-medicines/for-individuals/cough-and-cold-medicines-active-ingredients/paracetamol-phenylephrine-hydrochloride-guaifenesin |access-date=25 March 2014 |url-status=dead |archive-url=https://web.archive.org/web/20140326033356/http://www.nps.org.au/medicines/respiratory-system/cough-and-cold-medicines/for-individuals/cough-and-cold-medicines-active-ingredients/paracetamol-phenylephrine-hydrochloride-guaifenesin |archive-date=26 March 2014}}</ref><ref>{{cite web|url=http://www.nhs.uk/Conditions/Flu/Pages/selectorshow.aspx?medicine=Phenylephrine/Guaifenesin/Paracetamol |publisher=[[National Health Service]] |work=NHS Choices |title=Phenylephrine/Guaifenesin/Paracetamol |access-date=25 March 2014 |url-status=dead |archive-url= https://web.archive.org/web/20130912075213/http://www.nhs.uk/Conditions/Flu/Pages/selectorshow.aspx?medicine=Phenylephrine%2FGuaifenesin%2FParacetamol |archive-date=12 September 2013 }}</ref> is added to this combination.
Line 290 ⟶ 293:
 
===Cats===
Paracetamol is extremely toxic to cats, which lack the necessary [[UGT1A6]] enzyme to detoxify it. Initial symptoms include vomiting, salivation, and discoloration of the tongue and gums. Unlike an overdose in humans, liver damage is rarely the cause of death; instead, [[methemoglobin]] formation and the production of [[Heinz bodies]] in red blood cells inhibit oxygen transport by the blood, causing [[asphyxiation]] ([[methemoglobinemia]] and [[hemolytic anemia]]).<ref name="CanVetJ2003-Allen">{{cite journal |vauthors = Allen AL |title = The diagnosis of acetaminophen toxicosis in a cat |journal = The Canadian Veterinary Journal |volume = 44 |issue = 6 |pages = 509–10 |date = June 2003 |pmid = 12839249 |pmc = 340185 }}</ref> Treatment of the toxicosis with [[N-acetylcysteine]] is recommended.<ref name="Richardson_2000" />
 
===Dogs===
Paracetamol has been reported to be as effective as aspirin in the treatment of musculoskeletal pain in dogs.<ref name=smallani>{{cite book|title=Small Animal Clinical Pharmacology |vauthors = Maddison JE, Page SW, Church D |publisher=Elsevier Health Sciences|year=2002|isbn=978-0702025730|pages=260–1 }}</ref> A paracetamol–codeine product (brand name Pardale-V)<ref name="Pardale">{{cite web|title = Pardale-V Oral Tablets |work = NOAH Compendium of Data Sheets for Animal Medicines |publisher = The National Office of Animal Health (NOAH) |date=11 November 2010|access-date = 20 January 2011| url = http://www.noahcompendium.co.uk/Dechra_Veterinary_Products/documents/S3428.html| archive-url = https://web.archive.org/web/20081122104413/http://www.noahcompendium.co.uk/Dechra_Veterinary_Products/documents/S3428.html| url-status=dead| archive-date = 22 November 2008}}</ref> licensed for use in dogs is available for purchase under supervision of a vet, pharmacist or other qualified person.<ref name="Pardale" /> It should be administered to dogs only on veterinary advice and with extreme caution.<ref name="Pardale" />
 
The main effect of toxicity in dogs is liver damage, and GI ulceration has been reported.<ref name="Richardson_2000">{{cite journal |title=Management of acetaminophen and ibuprofen toxicoses in dogs and cats |vauthors=Richardson JA |journal=Journal of Veterinary Emergency and Critical Care |volume=10 |issue=4 |pages=285–291 |year=2000 |doi=10.1111/j.1476-4431.2000.tb00013.x |url=http://www.aspcapro.org/mydocuments/c-veccs_july00.pdf |url-status=dead |archive-date=1 April 2010 |archive-url= https://web.archive.org/web/20100401014830/http://www.aspcapro.org/mydocuments/c-veccs_july00.pdf}}</ref><ref name="VetHumToxicol1998-Villar">{{cite journal |vauthors=Villar D, Buck WB, Gonzalez JM |title=Ibuprofen, aspirin and acetaminophen toxicosis and treatment in dogs and cats |journal = Veterinary and Human Toxicology |volume=40 |issue=3 |pages=156–62 |date=June 1998 |pmid=9610496}}</ref><ref>{{cite journal |vauthors=Gwaltney-Brant S, Meadows I |title=The 10 Most Common Toxicoses in Dogs |journal=Veterinary Medicine |pages=142–148 |date=March 2006 |url= http://veterinarymedicine.dvm360.com/toxicology-brief-10-most-common-toxicoses-dogs |url-status=dead |archive-url= https://web.archive.org/web/20110710160759/http://veterinarymedicine.dvm360.com/vetmed/Medicine/ArticleStandard/Article/detail/314007 |archive-date=10 July 2011 |access-date=28 October 2019}}</ref><ref>{{cite journal |vauthors=Dunayer E |title=Ibuprofen toxicosis in dogs, cats, and ferrets |journal=Veterinary Medicine |pages=580–586 |year=2004 |url=http://veterinarymedicine.dvm360.com/vetmed/Medicine/ArticleStandard/Article/detail/651048|url-status=live|archive-url=https://web.archive.org/web/20110710160815/http://veterinarymedicine.dvm360.com/vetmed/Medicine/ArticleStandard/Article/detail/651048 |archive-date=10 July 2011}}</ref> N-acetylcysteineAcetylcysteine treatment is efficacious in dogs when administered within two hours of paracetamol ingestion.<ref name="Richardson_2000"/><ref name=smallani/>
 
===Snakes===